The Placebo Effect with Generics: Why Brand Names Feel Stronger
Explore the psychology behind why generic drugs sometimes feel less effective. Discover how the placebo and nocebo effects influence your health outcomes, backed by scientific studies.
Tag: bioequivalence
Understanding Therapeutic Equivalence Codes: How the FDA Rates Generic Drugs
Learn how the FDA uses therapeutic equivalence codes and the Orange Book to determine if generic drugs can be safely substituted for brand-name medications.
Why Some People React Differently to Generic Drugs: Safety and Efficacy Explained
Ever feel different after switching to a generic medication? Discover why bioequivalence and inactive ingredients cause individual reactions, especially with NTI drugs.
Cmax and AUC in Bioequivalence: What Peak Concentration and Drug Exposure Really Mean
Cmax and AUC are the two key metrics used globally to prove generic drugs work the same as brand-name versions. Cmax measures peak concentration, while AUC measures total exposure-both must fall within 80-125% of the original to ensure safety and effectiveness.
Drug Interactions: Are Generic and Brand Medications Equally Risky?
Generic and brand-name drugs have the same active ingredients, so their risk for drug interactions is essentially identical. Learn the science behind bioequivalence and why switching to generics is safe for most people.
